Product Development

Our lead compound, TAM-01, has undergone extensive pre-clinical testing to validate its potential in systemic lupus erythematosus (SLE) and is ready for the final steps necessary to file and investigational new drug application (IND). These steps include cGMP manufacturing and GLP Tox studies.

Along with its promise in SLE we are excited by the potential for TAM-01 in additional areas of high unmet need with additional pre-clinical screening in these areas commencing this year.

Copyright © 2019 / All rights reserved.Mount Tam Biomedical / Notices & Disclaimers